Skip Navigation

This Article
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Smitz, J.
Right arrow Articles by Cortvrindt, R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Smitz, J.
Right arrow Articles by Cortvrindt, R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 14, No. suppl_1, pp. 145-161, 1999
© 1999 European Society of Human Reproduction and Embryology

Oocyte in-vitro maturation and follicle culture: current clinical achievements and future directions

Johan Smitz1 and Rita Cortvrindt

Center for Reproductive Medicine, University Hospital and Medical School, Dutch-speaking Brussels Free University Laarbeeklaan 101, B-1090 Brussels, Belgium

Correspondence: 1To whom correspondence should be addressed

This paper reviews two recent developments in the field of assisted reproduction: in-vitro culture (IVC) of follicles and in-vitro maturation (IVM) of oocytes. Both in-vitro procedures for oocytes and immature follicles were developed so as to enable storage of ovarian cortical tissue and oocytecumulus complexes (OCC) from small follicles. Until now, complete in-vitro development from a primordial follicle up to ovulation has been achieved only in mice. Culture of ovarian cortex from large mammals and humans has revealed that the proliferation and differentiation of pre-granulosa cells is easily switched on, but that within a few days oocyte growth is often compromised. Culture of OCC from preantral follicles from sheep yielded antral follicles after 1 month in a serum-free system and the enclosed oocytes had almost doubled their diameter. Similar work in humans is ongoing, but no consistent successes have been reported as yet. In-vitro maturation of OCC from antral follicles has already been used clinically for more than 10 years. Inspired by the work on bovines, several in-vitro fertilization (IVF) clinics have applied IVM on OCC from different sizes of follicles. The culture conditions needed to provide a reasonable yield of developmentally competent oocytes have not been clearly defined, although some IVF groups have reported live births. To enable the development of consistent techniques of IVC and IVM, a more systematic and scientific approach is needed: use of defined culture media in combination with follicle stage-dependent supplements might improve our understanding of the minimal requirements for oocyte growth and maturation.

Key words: follicle/in-vitro maturation/meiosis/oocyte/ovary


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Hum Reprod UpdateHome page
I. Demeestere, P. Simon, S. Emiliani, A. Delbaere, and Y. Englert
Orthotopic and heterotopic ovarian tissue transplantation
Hum. Reprod. Update, November 1, 2009; 15(6): 649 - 665.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
A. Revel and J. Schenker
Ovarian tissue banking for cancer patients: is ovarian cortex cryopreservation presently justified?
Hum. Reprod., January 1, 2004; 19(1): 14 - 19.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.